DENTSPLY SIRONA Inc. (XRAY)
USD 18.68
(-2.66%)
USD 18.68
(-2.66%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -132 Million USD | 86.11% |
| 2022 | -950 Million USD | -331.14% |
| 2021 | 411 Million USD | 595.18% |
| 2020 | -83 Million USD | -131.57% |
| 2019 | 262.9 Million USD | 126.0% |
| 2018 | -1.01 Billion USD | 35.73% |
| 2017 | -1.57 Billion USD | -465.9% |
| 2016 | 429.9 Million USD | 71.14% |
| 2015 | 251.2 Million USD | -22.19% |
| 2014 | 322.85 Million USD | 3.09% |
| 2013 | 313.19 Million USD | -0.32% |
| 2012 | 314.21 Million USD | 28.5% |
| 2011 | 244.52 Million USD | -7.97% |
| 2010 | 265.7 Million USD | -3.12% |
| 2009 | 274.25 Million USD | -3.39% |
| 2008 | 283.86 Million USD | 9.33% |
| 2007 | 259.65 Million USD | 16.06% |
| 2006 | 223.71 Million USD | 392.63% |
| 2005 | 45.41 Million USD | -82.06% |
| 2004 | 253.16 Million USD | 45.34% |
| 2003 | 174.18 Million USD | 17.73% |
| 2002 | 147.95 Million USD | 21.78% |
| 2001 | 121.49 Million USD | 20.27% |
| 2000 | 101.01 Million USD | 12.36% |
| 1999 | 89.9 Million USD | 158.33% |
| 1998 | 34.8 Million USD | -53.35% |
| 1997 | 74.6 Million USD | 11.01% |
| 1996 | 67.2 Million USD | 24.44% |
| 1995 | 54 Million USD | -12.9% |
| 1994 | 62 Million USD | 339.72% |
| 1993 | 14.1 Million USD | 166.04% |
| 1992 | 5.3 Million USD | 82.76% |
| 1991 | 2.9 Million USD | 20.83% |
| 1990 | 2.4 Million USD | 41.18% |
| 1989 | 1.7 Million USD | 30.77% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4 Million USD | -122.22% |
| 2024 Q1 | 18 Million USD | -73.13% |
| 2023 Q4 | 67 Million USD | 125.19% |
| 2023 Q1 | -23 Million USD | -53.33% |
| 2023 FY | -132 Million USD | 86.11% |
| 2023 Q3 | -266 Million USD | -409.3% |
| 2023 Q2 | 86 Million USD | 473.91% |
| 2022 Q4 | -15 Million USD | 98.61% |
| 2022 Q3 | -1.07 Billion USD | -1575.34% |
| 2022 Q2 | 73 Million USD | 5.8% |
| 2022 Q1 | 69 Million USD | -32.35% |
| 2022 FY | -950 Million USD | -331.14% |
| 2021 Q2 | 96 Million USD | -14.29% |
| 2021 FY | 411 Million USD | 595.18% |
| 2021 Q4 | 102 Million USD | 21.43% |
| 2021 Q1 | 112 Million USD | 13.71% |
| 2021 Q3 | 84 Million USD | -12.5% |
| 2020 Q3 | 47 Million USD | 149.27% |
| 2020 FY | -83 Million USD | -131.57% |
| 2020 Q1 | -139.9 Million USD | -236.75% |
| 2020 Q4 | 98.5 Million USD | 109.57% |
| 2020 Q2 | -95.4 Million USD | 31.81% |
| 2019 FY | 262.9 Million USD | 126.0% |
| 2019 Q2 | 36.4 Million USD | -7.14% |
| 2019 Q4 | 102.3 Million USD | 20.35% |
| 2019 Q3 | 85 Million USD | 133.52% |
| 2019 Q1 | 39.2 Million USD | 2077.78% |
| 2018 Q1 | 81.2 Million USD | 112.06% |
| 2018 Q4 | 1.8 Million USD | -93.57% |
| 2018 Q3 | 28 Million USD | 102.5% |
| 2018 FY | -1.01 Billion USD | 35.73% |
| 2018 Q2 | -1.12 Billion USD | -1481.77% |
| 2017 Q4 | -673.4 Million USD | -843.27% |
| 2017 FY | -1.57 Billion USD | -465.9% |
| 2017 Q3 | 90.6 Million USD | 108.63% |
| 2017 Q2 | -1.05 Billion USD | -1855.85% |
| 2017 Q1 | 59.8 Million USD | -44.11% |
| 2016 FY | 429.9 Million USD | 71.14% |
| 2016 Q1 | 125 Million USD | 113.31% |
| 2016 Q4 | 107 Million USD | 15.68% |
| 2016 Q3 | 92.5 Million USD | -12.24% |
| 2016 Q2 | 105.4 Million USD | -15.68% |
| 2015 FY | 251.2 Million USD | -22.19% |
| 2015 Q3 | 84.5 Million USD | 91.61% |
| 2015 Q4 | 58.6 Million USD | -30.65% |
| 2015 Q2 | 44.1 Million USD | -31.09% |
| 2015 Q1 | 64 Million USD | -24.45% |
| 2014 Q3 | 75.3 Million USD | -16.33% |
| 2014 Q1 | 72.87 Million USD | -2.08% |
| 2014 FY | 322.85 Million USD | 3.09% |
| 2014 Q4 | 84.71 Million USD | 12.5% |
| 2014 Q2 | 89.99 Million USD | 23.48% |
| 2013 Q1 | 71.68 Million USD | -43.47% |
| 2013 Q2 | 87.22 Million USD | 21.68% |
| 2013 Q3 | 79.85 Million USD | -8.46% |
| 2013 Q4 | 74.42 Million USD | -6.79% |
| 2013 FY | 313.19 Million USD | -0.32% |
| 2012 Q1 | 53.28 Million USD | 31.23% |
| 2012 Q2 | 80.76 Million USD | 51.57% |
| 2012 Q3 | 53.36 Million USD | -33.93% |
| 2012 Q4 | 126.8 Million USD | 137.61% |
| 2012 FY | 314.21 Million USD | 28.5% |
| 2011 Q1 | 69.08 Million USD | 1.85% |
| 2011 FY | 244.52 Million USD | -7.97% |
| 2011 Q4 | 40.6 Million USD | -33.0% |
| 2011 Q3 | 60.59 Million USD | -18.37% |
| 2011 Q2 | 74.23 Million USD | 7.46% |
| 2010 Q2 | 72.38 Million USD | 17.05% |
| 2010 Q3 | 63.65 Million USD | -12.06% |
| 2010 Q4 | 67.82 Million USD | 6.56% |
| 2010 FY | 265.7 Million USD | -3.12% |
| 2010 Q1 | 61.84 Million USD | -17.36% |
| 2009 Q4 | 74.83 Million USD | 10.89% |
| 2009 FY | 274.25 Million USD | -3.39% |
| 2009 Q3 | 67.48 Million USD | -3.87% |
| 2009 Q1 | 61.74 Million USD | -13.03% |
| 2009 Q2 | 70.19 Million USD | 13.7% |
| 2008 Q4 | 70.99 Million USD | 7.49% |
| 2008 Q2 | 78.64 Million USD | 15.35% |
| 2008 Q1 | 68.18 Million USD | -2.64% |
| 2008 FY | 283.86 Million USD | 9.33% |
| 2008 Q3 | 66.04 Million USD | -16.02% |
| 2007 Q4 | 70.03 Million USD | 6.56% |
| 2007 Q1 | 58.47 Million USD | -9.97% |
| 2007 FY | 259.65 Million USD | 16.06% |
| 2007 Q2 | 65.43 Million USD | 11.9% |
| 2007 Q3 | 65.71 Million USD | 0.44% |
| 2006 FY | 223.71 Million USD | 392.63% |
| 2006 Q4 | 64.94 Million USD | 31.35% |
| 2006 Q3 | 49.44 Million USD | -16.63% |
| 2006 Q2 | 59.31 Million USD | 18.62% |
| 2006 Q1 | 50 Million USD | 7006.63% |
| 2005 Q2 | 57.89 Million USD | 18.03% |
| 2005 Q3 | -60.8 Million USD | -205.03% |
| 2005 Q4 | -724 Thousand USD | 98.81% |
| 2005 Q1 | 49.04 Million USD | -28.51% |
| 2005 FY | 45.41 Million USD | -82.06% |
| 2004 Q1 | 88.83 Million USD | 76.31% |
| 2004 Q4 | 68.6 Million USD | 46.96% |
| 2004 Q3 | 46.68 Million USD | -4.81% |
| 2004 Q2 | 49.04 Million USD | -44.79% |
| 2004 FY | 253.16 Million USD | 45.34% |
| 2003 Q1 | 38.26 Million USD | -9.47% |
| 2003 Q4 | 50.38 Million USD | 21.95% |
| 2003 Q3 | 41.31 Million USD | -6.57% |
| 2003 Q2 | 44.21 Million USD | 15.55% |
| 2003 FY | 174.18 Million USD | 17.73% |
| 2002 FY | 147.95 Million USD | 21.78% |
| 2002 Q3 | 35.76 Million USD | -2.86% |
| 2002 Q4 | 42.26 Million USD | 18.18% |
| 2002 Q1 | 33.09 Million USD | -2.22% |
| 2002 Q2 | 36.82 Million USD | 11.25% |
| 2001 Q3 | 25.91 Million USD | -5.42% |
| 2001 Q4 | 33.84 Million USD | 30.59% |
| 2001 Q1 | 34.32 Million USD | 11.22% |
| 2001 Q2 | 27.4 Million USD | -20.17% |
| 2001 FY | 121.49 Million USD | 20.27% |
| 2000 Q4 | 30.86 Million USD | 32.26% |
| 2000 Q3 | 23.33 Million USD | -5.25% |
| 2000 Q2 | 24.62 Million USD | 10.97% |
| 2000 Q1 | 22.19 Million USD | -22.13% |
| 2000 FY | 101.01 Million USD | 12.36% |
| 1999 Q3 | 20.7 Million USD | -2.36% |
| 1999 FY | 89.9 Million USD | 158.33% |
| 1999 Q1 | 19.5 Million USD | 912.5% |
| 1999 Q2 | 21.2 Million USD | 8.72% |
| 1999 Q4 | 28.5 Million USD | 37.68% |
| 1998 Q3 | 17.6 Million USD | 2833.33% |
| 1998 Q4 | -2.4 Million USD | -113.64% |
| 1998 FY | 34.8 Million USD | -53.35% |
| 1998 Q1 | 19 Million USD | -19.49% |
| 1998 Q2 | 600 Thousand USD | -96.84% |
| 1997 Q2 | 17.8 Million USD | 5.33% |
| 1997 FY | 74.6 Million USD | 11.01% |
| 1997 Q4 | 23.6 Million USD | 44.79% |
| 1997 Q3 | 16.3 Million USD | -8.43% |
| 1997 Q1 | 16.9 Million USD | -17.96% |
| 1996 Q2 | 17.8 Million USD | 18.67% |
| 1996 FY | 67.2 Million USD | 24.44% |
| 1996 Q4 | 20.6 Million USD | 48.2% |
| 1996 Q3 | 13.9 Million USD | -21.91% |
| 1996 Q1 | 15 Million USD | -18.03% |
| 1995 FY | 54 Million USD | -12.9% |
| 1995 Q4 | 18.3 Million USD | 92.63% |
| 1995 Q3 | 9.5 Million USD | -28.03% |
| 1995 Q2 | 13.2 Million USD | 1.54% |
| 1995 Q1 | 13 Million USD | -40.37% |
| 1994 FY | 62 Million USD | 339.72% |
| 1994 Q1 | 12.4 Million USD | 4233.33% |
| 1994 Q2 | 14 Million USD | 12.9% |
| 1994 Q3 | 13.9 Million USD | -0.71% |
| 1994 Q4 | 21.8 Million USD | 56.83% |
| 1993 FY | 14.1 Million USD | 166.04% |
| 1993 Q4 | -300 Thousand USD | -102.73% |
| 1993 Q3 | 11 Million USD | 361.9% |
| 1993 Q2 | -4.2 Million USD | -187.5% |
| 1993 Q1 | 4.8 Million USD | 11.63% |
| 1992 Q2 | 2.1 Million USD | 23.53% |
| 1992 FY | 5.3 Million USD | 82.76% |
| 1992 Q3 | 3.5 Million USD | 66.67% |
| 1992 Q4 | 4.3 Million USD | 22.86% |
| 1992 Q1 | 1.7 Million USD | 13.33% |
| 1991 Q2 | 900 Thousand USD | 28.57% |
| 1991 Q3 | 1.2 Million USD | 33.33% |
| 1991 FY | 2.9 Million USD | 20.83% |
| 1991 Q1 | 700 Thousand USD | 0.0% |
| 1991 Q4 | 1.5 Million USD | 25.0% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1990 FY | 2.4 Million USD | 41.18% |
| 1990 Q3 | 700 Thousand USD | 0.0% |
| 1990 Q2 | 700 Thousand USD | 16.67% |
| 1990 Q1 | 600 Thousand USD | 0.0% |
| 1989 Q4 | 600 Thousand USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | 600 Thousand USD | 20.0% |
| 1989 Q2 | 500 Thousand USD | 0.0% |
| 1989 FY | 1.7 Million USD | 30.77% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | -108.455% |
| AngioDynamics, Inc. | -184.34 Million USD | 28.397% |
| AtriCure, Inc. | -30.43 Million USD | -333.668% |
| Avinger, Inc. | -18.32 Million USD | -620.524% |
| Azenta, Inc. | -14.25 Million USD | -825.861% |
| BioLife Solutions, Inc. | -66.42 Million USD | -98.714% |
| The Cooper Companies, Inc. | 294.2 Million USD | 144.867% |
| Daxor Corporation | 280.64 Thousand USD | 47135.348% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | -768.535% |
| Femasys Inc. | -14.24 Million USD | -826.503% |
| GlucoTrack, Inc. | -7.09 Million USD | -1759.941% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -3765.3% |
| Hologic, Inc. | 789.5 Million USD | 116.719% |
| ICU Medical, Inc. | -29.65 Million USD | -345.119% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 107.341% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -860.624% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 538.465% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -1880.962% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -1880.962% |
| Masimo Corporation | 81.5 Million USD | 261.963% |
| Microbot Medical Inc. | -10.74 Million USD | -1129.05% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 1235.443% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 239.814% |
| Nephros, Inc. | -1.57 Million USD | -8280.952% |
| NovoCure Limited | -207.04 Million USD | 36.245% |
| NEXGEL, Inc. | -3.15 Million USD | -4081.185% |
| NEXGEL, Inc. | -3.15 Million USD | -4081.185% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | -39.211% |
| OraSure Technologies, Inc. | 53.65 Million USD | 346.016% |
| Pro-Dex, Inc. | 2.12 Million USD | 6305.924% |
| Pulse Biosciences, Inc. | -42.21 Million USD | -212.722% |
| Predictive Oncology Inc. | -13.98 Million USD | -843.938% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -4372.489% |
| QuidelOrtho Corporation | -10.1 Million USD | -1206.931% |
| Repligen Corporation | 41.57 Million USD | 417.483% |
| Sanara MedTech Inc. | -4.3 Million USD | -2967.487% |
| STAAR Surgical Company | 21.34 Million USD | 718.354% |
| Sharps Technology, Inc. | -9.84 Million USD | -1241.24% |
| Utah Medical Products, Inc. | 16.63 Million USD | 893.508% |
| Jin Medical International Ltd. | 2.87 Million USD | 4686.152% |